ADDED
The Company has not selected any specific Business Combination target.
As of September 30, 2025, the Company had not commenced any operations.
Transaction costs related to the Initial Public Offering amounted to $ 7,537,261 , consisting of $ 250,000 of cash underwriting fee, $ 6,600,000 of deferred underwriting fee and $ 687,261 of other offering costs.
Liquidity, Capital Resources and Going Concern As of September 30, 2025, the Company had operating cash and cash equivalents of $ 141,921 and a working capital surplus of $ 98,807 .
Additionally, if a Business Combination is not consummated by the end of the Combination Period, currently August 14, 2026 (February 14, 2027 if the Company executes a definitive business combination agreement), there will be a mandatory liquidation and subsequent dissolution of the Company.
The Company s liquidity condition and mandatory liquidation within one year of the issuance of these unaudited condensed financial statements raise substantial doubt about the Company s ability to continue as a going concern.
However, there can be no assurance that the Company will be able to consummate any Business Combination by the end of the Combination Period.
The Company had $ 141,921 and $ 0 in cash and $ 0 and $ 0 cash equivalents as of September 30, 2025 and December 31, 2024, respectively.
Treasury Securities and $ 937 was held in cash at an amortized cost of $ 225,851,431 as reflected on the accompanying condensed balance sheets (see note 8).
Transaction costs related to the Initial Public Offering amounted to $ 7,537,261 , consisting of $ 250,000 of cash underwriting fee, $ 6,600,000 of deferred underwriting fee and $ 687,261 of other offering costs.
REMOVED
Interim Financial Statements Condensed Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024 1 Condensed Statements of Operations for the Three and Six Months Ended June 30, 2025 (Unaudited) 2 Condensed Statements of Changes in Shareholders Deficit for the Three and Six Months Ended June 30, 2025 (Unaudited) 3 Condensed Statement of Cash Flows for the Six Months Ended June 30, 2025 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5 Item 2.
The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company.
As of June 30, 2025, the Company had not commenced any operations.
Transaction costs amounted to $ 7,537,261 , consisting of $ 250,000 of cash underwriting fee, $ 6,600,000 of deferred underwriting fee and $ 687,261 of other offering costs.
Liquidity, Capital Resources and Going Concern As of June 30, 2025, the Company had operating cash and cash equivalents of $ 240,391 and a working capital surplus of $ 302,460 .
The Company s liquidity condition raises substantial doubt about the Company s ability to continue as a going concern for a period of time within one year after the date that the accompanying condensed financial statements are issued.
The Company had $ 37,942 and $ 0 in cash and $ 202,449 and $ 0 cash equivalents as of June 30, 2025 and December 31, 2024, respectively.
Transaction costs amounted to $ 7,537,261 , consisting of $ 250,000 of cash underwriting fee, $ 6,600,000 of deferred underwriting fee and $ 687,261 of other offering costs.
For the three and six months ended June 30, 2025, the Company incurred and paid $ 75,000 and $ 112,500 in fees for these services, respectively.
As of June 30, 2025, assets held in the Trust Account were comprised of $ 486 in cash and $ 223,340,828 invested in U.S.